Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

11.10
Delayed Data
As of Feb 17
 +0.36 / +3.35%
Today’s Change
8.70
Today|||52-Week Range
21.22
+20.65%
Year-to-Date
Marijuana Stocks: Plenty of Business Diversity, Yet One Common Theme
Feb 18 / MotleyFool.com - Paid Partner Content
Gurus' Worst Recent Investments
Feb 15 / GuruFocus News - Paid Partner Content
Here's Why This Marijuana Stock Jumped 15% This Week
Feb 17 / MotleyFool.com - Paid Partner Content
7 of the Worst Stocks in Gurus' Portfolios
Feb 13 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close10.74
Today’s open10.71
Day’s range10.56 - 11.15
Volume1,392,172
Average volume (3 months)900,006
Market cap$796.6M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-77.90%
Earnings growth (next 5 years)+65.00%
Revenue growth (last year)+48.92%
P/E ratio35.8
Price/Sales6.55
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.35+3.06%
CLLSCellectis SA-0.10-0.44%
AKAOAchaogen Inc+0.68+3.09%
LCILannett Company Inc-0.60-2.61%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Medical Officer
Santosh J. Vetticaden
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts


Search for Jobs